2013
DOI: 10.1074/jbc.m113.453688
|View full text |Cite
|
Sign up to set email alerts
|

p39, the Primary Activator for Cyclin-dependent Kinase 5 (Cdk5) in Oligodendroglia, Is Essential for Oligodendroglia Differentiation and Myelin Repair

Abstract: Background: Cyclin-dependent kinase 5 (Cdk5) is crucial for brain development. Results: In contrast to neurons that utilize p35 as the primary Cdk5 activator, oligodendroglia employ p39-dependent Cdk5 activation to advance differentiation and myelin repair. Conclusion: p39 is the primary Cdk5 activator in oligodendroglia, essential for oligodendroglia development. Significance: Our study revealed distinct mechanisms controlling Cdk5 activity in neurons and oligodendroglia.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
10
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 14 publications
(10 citation statements)
references
References 55 publications
0
10
0
Order By: Relevance
“…P39 is the principal Cdk5 activator in oligodendroglia and is required for myelin repair and oligodendroglial differentiation [30]. Cdk5/p39 is also responsible for Munc18-1 phosphorylation during Ca ++ -induced insulin exocytosis [31] and phosphorylates the microtubule protein tau in the developing mouse brain [31].…”
Section: Discussionmentioning
confidence: 99%
“…P39 is the principal Cdk5 activator in oligodendroglia and is required for myelin repair and oligodendroglial differentiation [30]. Cdk5/p39 is also responsible for Munc18-1 phosphorylation during Ca ++ -induced insulin exocytosis [31] and phosphorylates the microtubule protein tau in the developing mouse brain [31].…”
Section: Discussionmentioning
confidence: 99%
“…The expression of p39, but not p35, is upregulated during remyelinization and is essential for the repair of myelin lesions. 21 In addition, both regulatory subunits also have different abilities to phosphorylate tau, but only Cdk5/p39 is involved in the in vivo phosphorylation of tau at Ser-202 and Thr-205 during brain development. 12 Discrete-specific roles for both activators have been demonstrated in nonneuronal cells as well.…”
Section: Discussionmentioning
confidence: 99%
“…Even though p35 −/− mice are viable and fertile, they display subtle impaired neuronal migration and inverted neuronal layering in the cerebral cortex along with abnormal hippocampus morphology. 19 In contrast, mice lacking p39 have no obvious phenotypic defects or apparent abnormalities 20 but show impaired remyelination 21 and exhibit defects in axonal growth and dendritic spine formation. 22 Compound deletion of both Cdk5 activators results in perinatal lethality 20 and a phenotype that is nearly identical to the Cdk5 −/− mice, 6 which suggests that both p35 and p39 are major activators of Cdk5 that contribute to in vivo activation of Cdk5 in a region-specific and developmentally regulated manner.…”
Section: Introductionmentioning
confidence: 99%
“…Understanding possible glial migrational roles of Cdk5 in nestin-lineage progenitors would reveal common or divergent roles for this regulator in neurons vs. glial cells, similar to what has been found using in vivo [19,20,73] and in vitro [2628] migrational assays. Future experiments examining the role of Cdk5 in early postnatal glial migration of nestin-expressing progenitors as well as the biochemical and molecular underpinnings of its role would therefore require separate, comprehensive study employing in vivo , in vitro , and ex vivo strategies [20,62,7479]. It is also possible that in addition to impaired proliferation, differentiation/maturation, and migration, early deficits in the nestin-expressing progenitors may contribute to the iCdk5 phenotype.…”
Section: Discussionmentioning
confidence: 99%